drugset / Trial / NCT00190957

Atomoxetine Treatment of Adults With ADHD and Comorbid Alcohol Abuse

NCT00190957

Phase 4 Completed 140 enrolled Eli Lilly and Company
RandomizedParallel-groupDouble-blindTreatment

Summary

Atomoxetine Treatment of Adults with ADHD and Comorbid Alcohol Abuse

Timeline

Start
2004-08
Primary completion
Completion
2006-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Atomoxetine Other / unclassified 100 mg